Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Please Wait
Applying Filters...
01 13Evonik
02 2SPI Pharma
03 4Actylis
04 3Alcedo Pharmachem
05 42BASF
06 7Gangwal Chemicals
07 2Microlex e.U
08 4Roquette
09 1The Dow Chemical Company
10 3Valens Pharmachem
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
SPI Pharma has been solving formulation challenges using superior functional materials.
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Application : Fillers, Diluents & Binders, Granulation, Solubilizers
Excipient Details : Mannogem (mannitol powder) is an excellent excipient for use in wet granulation, lyophilization & improves solubility of poorly soluble APIs.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Mannitol
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
SPI Pharma has been solving formulation challenges using superior functional materials.
Ingredient(s) : Mannitol
Dosage Form : Granule / Pellet, Tablet
Category : Fillers, Diluents & Binders, Granulation, Solubilizers
Brand : MANNOGEM POWDER
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® RL 100 (granules) is an excipient used as a solubilizer in combination with Eudragit® RS for creating sustained release drugs.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ammonia Methacrylate Copolymer Type A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® RL 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ammonio Methacrylate Copolymer Type B
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® RS 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Solubilizers
Excipient Details : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Category : Solubilizers
Brand : EUDRAGIT® L 12,5
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Solubilizers
Excipient Details : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Category : Solubilizers
Brand : EUDRAGIT® S 12,5
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
